ACM
OPTN

Aster Capital Management’s OptiNose OPTN Stock Holding History

Aster Capital Management’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,898
Closed -$26K – 1566
2024
Q4 		$26K Sell
3,898
-1
-0% -$9 0.01% 596
2024
Q3 		$39.2K Buy
+3,899
New +$56.9K 0.01% 553

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Aster Capital Management's OPTN Position: Q1 2025 in Review

Aster Capital Management sold out of OptiNose (OPTN) in Q1 2025, closing a stake of 3,898 shares — an estimated $26K sold.

Aster Capital Management first reported a position in OPTN in Q3 2024 and held it in 2 quarters. The position peaked at $39.2K in Q3 2024. 43 funds tracked by Wall St. Rank hold OPTN as of Q1 2025.

  • Aster Capital Management reported no remaining OptiNose position as of Q1 2025 after selling out during the quarter.
  • Aster Capital Management sold 3,898 OptiNose shares in Q1 2025, an estimated $26K.
  • Aster Capital Management first reported a position in OptiNose in Q3 2024 and held it in 2 quarters.
  • Aster Capital Management's OptiNose position peaked at $39.2K in Q3 2024.
  • 43 funds tracked by Wall St. Rank held OptiNose as of Q1 2025.

Based on Aster Capital Management's 13F filing for Q1 2025, filed 15 May 2025.